OptimizeD Pilot Study
NCT06153004 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 76
Last updated 2024-04-09
Summary
This pilot study aims to explore and refine the trial procedures that will be implemented in a larger-scale clinical trial scheduled to commence in March 2024 (NCT05944926). As part of this study, 60 patients with moderate to severe depression will be randomized to either psychotherapy based on behavioral activation called the Healthy Activity Program (HAP) or antidepressant medication.
The pilot study has two primary objectives:
1. Evaluate the feasibility and acceptability of the study
2. Collect essential outcome data in preparation for the larger trial
Conditions
- Depression
- Depressive Disorder
Interventions
- BEHAVIORAL
-
Healthy Activity Program (HAP)
HAP, delivered over 6-8 sessions by non-specialist healthcare workers, has behavioural activation as the core psychological strategy along with other strategies such as problem-solving and activation of social networks.
- DRUG
-
Antidepressant medication (ADM)
Patients assigned to antidepressant medication will start on fluoxetine 20 mg/day which can be raised to 40 mg/day (the maximum mandated by treatment guidelines for primary care in India) at week 3 or 6 for patients who have yet to remit. Patients who cannot tolerate fluoxetine will be switched to escitalopram.
Sponsors & Collaborators
-
National Institute of Mental Health (NIMH)
collaborator NIH -
Harvard School of Public Health (HSPH)
collaborator OTHER -
Massachusetts General Hospital
collaborator OTHER -
Centre for Addiction and Mental Health
collaborator OTHER -
Brigham and Women's Hospital
collaborator OTHER -
Vanderbilt University
collaborator OTHER -
All India Institute of Medical Sciences, Bhopal
collaborator OTHER -
Sangath
collaborator OTHER -
Harvard Medical School (HMS and HSDM)
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-08-01
- Primary Completion
- 2024-03-10
- Completion
- 2024-03-31
Countries
- India
Study Locations
More Related Trials
-
Studying Patterns in Patient Engagement Among Treatment Resistant Depression Patients
NCT06101914 ·Status: NOT_YET_RECRUITING
-
Implementation of Harmonized Depression Outcome Measures in a Health System
NCT04235712 ·Status: COMPLETED
-
Implementation of Harmonized Depression Outcome Measures in a Primary Care Registry and a Mental Health Registry
NCT04235725 ·Status: COMPLETED
-
Organized Self-Management Support Services for Chronic Depression
NCT01139060 ·Status: COMPLETED ·Phase: PHASE3
-
Organized Self-management Support for Chronic Depression
NCT00169286 ·Status: COMPLETED ·Phase: NA
-
Pilot Study of Open-label Placebo to Treat Major Depressive Disorder
NCT01103271 ·Status: COMPLETED ·Phase: PHASE2
-
Medication Treatment for Depression in Nursing Home Residents
NCT00076622 ·Status: COMPLETED
-
RCT of Brain Longitudinal Biomarker Study (OPT-Neuro RCT)
NCT05531591 ·Status: COMPLETED ·Phase: PHASE4
-
Sensor-based Characterization of Depression
NCT04370002 ·Status: RECRUITING
-
Personalized Ultrasonic Brain Stimulation for Depression
NCT05301036 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Remote Coaching for Supporting the Implementation of Depression Care in Primary Care in Rural India
NCT05264792 ·Status: COMPLETED ·Phase: NA
-
Efficacy Study of a Computer Decision Support System to Treat Depression
NCT00551083 ·Status: COMPLETED ·Phase: NA
-
Reducing Hospital Readmissions in Patients With Depressive Symptoms
NCT01840826 ·Status: COMPLETED ·Phase: NA
-
Improving Outcomes of Depression in Primary Care
NCT00105833 ·Status: COMPLETED ·Phase: NA
-
Vortioxetine for Menopausal Depression
NCT02234362 ·Status: COMPLETED ·Phase: PHASE4
-
Eealy Improvement Predicts Antidepressants Response in Adults With Major Depression Disorder
NCT03230682 ·Status: UNKNOWN
-
Outreach and Treatment for Depression in the Labor Force
NCT00057590 ·Status: COMPLETED ·Phase: NA
-
Management of Depression in Primary Care
NCT01402206 ·Status: COMPLETED ·Phase: NA
-
Tailored Implementation Intervention for Managing Depressed Elderly Patients in Primary Care
NCT01913236 ·Status: COMPLETED ·Phase: NA
-
Algorithm Guided Treatment Strategies for Major Depressive Disorder
NCT01764867 ·Status: UNKNOWN ·Phase: PHASE4
-
Treatment for Depression in the Primary Care Setting
NCT00055328 ·Status: COMPLETED ·Phase: PHASE4
-
Antidepressant Medication Plus Directly Observed Therapy for Improving Adherence to Antiretroviral Therapy
NCT00338767 ·Status: COMPLETED ·Phase: PHASE2
-
Augmented Human Intelligence in Major Depressive Disorder
NCT04355650 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Mirtazapine in Depressed Cocaine Dependent Subjects
NCT00322309 ·Status: COMPLETED ·Phase: PHASE2
-
Lifestyle Medicine for Depression 2019
NCT04070417 ·Status: UNKNOWN ·Phase: NA